文献速递心境障碍精神分裂症与精神病性障碍老年精神

氧化应激诱导的核酸损伤与成人精神障碍的关联:系统综述与荟萃分析

Association of Oxidative Stress-Induced Nucleic Acid Damage With Psychiatric Disorders in Adults: A Systematic Review and Meta-analysis.
PubMed 文献 · JAMA Psychiatry · 2022-01-01

合并效应量从尿液DNA标志物的中等效应(SMD=0.44)到血细胞DNA标志物的极大效应(SMD=1.12)不等,痴呆患者升高最明显,其次为精神病性和双相障碍。作者认为核酸氧化损伤可能与精神障碍患者躯体疾病发病和死亡风险相关。

要点

  • 精神障碍患者核酸氧化损伤标志物水平较对照升高,血细胞DNA标志物效应量最大(SMD=1.12)。
  • 痴呆患者核酸氧化损伤水平最高,其次为精神病性和双相障碍患者。
  • 排除低质量研究的敏感性分析未实质性改变结果;干预研究太少且异质性大,未能进行有意义的荟萃分析。

核心结论

  • 该荟萃分析结果提示,跨精神障碍诊断谱系的个体核酸氧化损伤水平升高存在关联。
  • 核酸氧化损伤可能在精神障碍患者观察到的躯体疾病发病和死亡中发挥作用。

研究设计与样本

  • 纳入标准为成人研究,测量任何DNA或RNA氧化应激损伤标志物,且为比较精神障碍患者(任何诊断)与对照组的横断面设计或前瞻性干预研究。
  • 两名作者独立筛选文献和数据提取,分歧时咨询资深作者;采用随机效应和多水平荟萃分析合成数据。

主要发现

  • 总体数据显示,精神障碍患者跨基质和分子的核酸氧化损伤水平高于对照。
  • 尿液DNA标志物合并效应量为中等(SMD=0.44 [95% CI, 0.20-0.68]; P < .001)。
  • 血细胞DNA标志物合并效应量为极大(SMD=1.12 [95% CI, 0.69-1.55]; P < .001)。
  • 核酸氧化损伤水平升高在痴呆患者中最明显,其次为精神病性和双相障碍患者。
  • 排除低质量研究的敏感性分析未实质性改变结果;干预研究数量少且异质性大,未能进行有意义的荟萃分析。

关键数值与推荐

  • 主要结局为患者与对照间核酸氧化标志物的标准化均数差(SMD),按诊断组比较,分析分为生物基质与核酸的组合。
  • 尿液DNA标志物:SMD=0.44(95% CI, 0.20-0.68; P < .001)。
  • 血细胞DNA标志物:SMD=1.12(95% CI, 0.69-1.55; P < .001)。

临床怎么用

  • 原文未提供临床实践推荐。

局限性

  • 干预研究数量少且异质性大,未能进行有意义的荟萃分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Nucleic acid damage from oxidative stress (NA-OXS) may be a molecular mechanism driving the severely increased morbidity and mortality from somatic causes in adults with psychiatric disorders. OBJECTIVE: To systematically retrieve and analyze data on NA-OXS across the psychiatric disorder diagnostic spectrum. DATA SOURCES: The PubMed, Embase, and PsycINFO databases were searched from inception to November 16, 2021. A hand search of reference lists of relevant articles was also performed. STUDY SELECTION: Key study inclusion criteria in this meta-analysis were as follows: adult human study population, measurement of any marker of DNA or RNA damage from oxidative stress, and either a (1) cross-sectional design comparing patients with psychiatric disorders (any diagnosis) with a control group or (2) prospective intervention. Two authors screened the studies, and 2 senior authors read the relevant articles in full and assessed them for eligibility. DATA EXTRACTION AND SYNTHESIS: The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines were followed. Two authors performed data extraction independently, and a senior coauthor was consulted in cases of disagreement. Data were synthesized with random-effects and multilevel meta-analyses. MAIN OUTCOMES AND MEASURES: The predefined hypothesis was that individuals with psychiatric disorders have increased NA-OXS levels. The main outcome was the standardized mean differences (SMDs) among patients and controls in nucleic acid oxidation markers compared across diagnostic groups. Analyses were divided into combinations of biological matrices and nucleic acids. RESULTS: Eighty-two studies fulfilled the inclusion criteria, comprising 205 patient vs control group comparisons and a total of 10 151 patient and 10 532 control observations. Overall, the data showed that patients with psychiatric disorders had higher NA-OXS levels vs controls across matrices and molecules. Pooled effect sizes ranged from moderate for urinary DNA markers (SMD = 0.44 [95% CI, 0.20-0.68]; P < .001) to very large for blood cell DNA markers (SMD = 1.12 [95% CI, 0.69-1.55; P < .001). Higher NA-OXS levels were observed among patients with dementias followed by psychotic and bipolar disorders. Sensitivity analyses excluding low-quality studies did not materially alter the results. Intervention studies were few and too heterogenous for meaningful meta-analysis. CONCLUSIONS AND RELEVANCE: The results of this meta-analysis suggest that there is an association with increased NA-OXS levels in individuals across the psychiatric disorder diagnostic spectrum. NA-OXS may play a role in the somatic morbidity and mortality observed among individuals with psychiatric disorders.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Jorgensen A, Baago IB, Rygner Z, et al. Association of Oxidative Stress-Induced Nucleic Acid Damage With Psychiatric Disorders in Adults: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2022. PMID: 35921094. doi:10.1001/jamapsychiatry.2022.2066

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。